Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Leuk Lymphoma. 2021 Aug 26;63(1):74–83. doi: 10.1080/10428194.2021.1971223

Figure 3.

Figure 3.

Disease specific survival from start of salvage immunochemotherapy for all patients (A) and according to response by visual assessment and ΔSUVmax cutoff of 50% on PET/CT from D4 (B-C) and D21 (D-E), respectively.

D: day; PET: positron emission tomography; SD: stable disease; PD: progressive disease; CR: complete response; PR: partial response; SUVmax: maximum standardized uptake value.